Skip to main content
Top
Published in: NanoEthics 1/2018

03-03-2018 | Original Paper

Person Skilled in the Art in Synthetic Biology from Iraqi and Malaysian Perspectives

Authors: Zinatul Ashiqin Zainol, Nabeel Mahdi Althabhawi

Published in: NanoEthics | Issue 1/2018

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

This article presents the problem of a person skilled in the field of synthetic biology. The person skilled in the art is one of the notions which have to be revisited due to the multidisciplinary nature of synthetic biology which involves numerous fields. The article studies this problem from the perspectives of Iraqi and Malaysian patent laws. First, it conceptualizes synthetic biology and person skilled in the art. The Iraqi and Malaysian attitudes regarding person skilled in the art are then addressed. Afterwards, the paper points out the multidisciplinary nature of synthetic biology. In its last part, it discusses the person skilled in synthetic biology and how patent offices and courts deal with this point. Finally, the authors submit that the use of a team of skilled persons to substitute for a single technician would render the obviousness test a subjective assessment dependent on the inventor. The level of non-obviousness would differ in similar cases simply because of the number of inventors. Consequently, the suggestion of having a hypothetical team instead of one person is irrelevant because skills that are attributed to the skilled notional person are not real skills. Thus, replacing him is easy, but the replacement would be fruitless because the skills attributed to a person or a team will be similar.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Footnotes
1
Synthetic biology has introduced many new topics, such as synthesized genes and proteins with extra amino acids.
 
2
An example of these principles is that of the human genetic makeup that has been altered by the emergence of synthetic biology.
 
4
For instance, see section Article 2 in the Iraqi patent act, section 15 in the Malaysian patent act, and section 3 in the UK patent act of 1977.
 
5
See section 103 in the US patent act.
 
6
Section 3
 
7
Art. 56 of European Patent Convention
 
8
Section 15
 
9
Article 1(1) of the Directive No. 1 1990 for the performance directive of the Iraqi Patent states, “An invention shall be considered innovative if it would not be obvious to skilled people with respect to the state-of-the-art at the filing date.”
 
10
Neuberger J. said, “The court will normally be hearing from experts…” Amgen Parties v Roche Parties [2001] EWHC 433.
 
11
Hoechst Celanese v BP [1997] FSR 547, p 563; Synthon BV v. Smithkline Beecham plc [2006] RPC 10, p 27
 
12
Beloit v Valmet [1997] RPC 489, p 494, by Aldous LJ. See also Eli Lilly and Company V Human Genome Sciences, Inc. [2008] RPC 29, p 30.
 
13
Raychem Corporation Patent, p 504, line 19; Schlumberger Holdings Ltd. v Electromagnetic Geoservices AS [2009] PRC 19
 
14
Generics (UK) v Daiichi Pharmaceutical [2008] EWHC 2413 (pat) http://​www.​bailii.​org/​ew/​cases/​EWHC/​Patents/​2008/​2413.​html (24 February 2013)
 
15
At para 40
 
16
Ronic Corporation v Cadware Sdn Bhd [2012] 1 LNS 330
 
17
At p 24
 
18
Sanofi-Aventis (Malaysia) SDN BHD & ANOR v. Fresenius Kabi (Malaysia) SDN BHD & ANOR, [2012] 4 CLJ 532, at 547 and 548
 
19
Ranbaxy (Malaysia) Sdn Bhd v. E.I Du Pont Nemours & CO [2012] 9 CLJ at 96
 
20
Sanofi-Aventis (Malaysia) SDN BHD & ANOR v. Fresenius Kabi (Malyasia) SDN BHD & ANOR, [2012] 4 CLJ 532, at 574
 
21
At p 727
 
22
Boehringer Mannheim v Genzyme [1993] RPC 716 at p 727; Amgen Parties v. Roche Parties [2001] EWHC Patents 433
 
23
Genentechs Patent, 278, (Mustill LJ)
 
24
Dillon J. in Genentech patent [1989] at p 241; see the same point in Nokia GmbH v Ipcom GmbH & Co. KG [2009] EWHC 3482 (Pat).
 
25
This statement was delivered by Laddie J. in Pfizer Ltd.’s patent [2001].
 
26
Genentech Inc., Patent [1989] RPC 147, at p 214
 
Literature
1.
go back to reference Maclurcan DC (2009) Southern roles in global nanotechnology innovation: perspectives from Thailand and Australia. NanoEthics 3(2):137–156CrossRef Maclurcan DC (2009) Southern roles in global nanotechnology innovation: perspectives from Thailand and Australia. NanoEthics 3(2):137–156CrossRef
2.
go back to reference Althabhawi N, Zainol Z (2013) Patentable novelty in nanotechnology inventions: a legal study in Iraq and Malaysia. NanoEthics 7(2):121–133CrossRef Althabhawi N, Zainol Z (2013) Patentable novelty in nanotechnology inventions: a legal study in Iraq and Malaysia. NanoEthics 7(2):121–133CrossRef
3.
go back to reference Allhoff F (2007) On the autonomy and justification of nanoethics. NanoEthics 1(3):185–210CrossRef Allhoff F (2007) On the autonomy and justification of nanoethics. NanoEthics 1(3):185–210CrossRef
4.
go back to reference Yeh BJ, Lim WA (2007) Synthetic biology: lessons from the history of synthetic organic chemistry. Nat Chem Biol 3(9):521–525CrossRef Yeh BJ, Lim WA (2007) Synthetic biology: lessons from the history of synthetic organic chemistry. Nat Chem Biol 3(9):521–525CrossRef
5.
go back to reference Leduc S (1912) La biologie synthétique. Poinat, Paris Leduc S (1912) La biologie synthétique. Poinat, Paris
6.
go back to reference Szybalski W (1974) In vivo and in vitro initiation of transcription. Adv Exp Med Biol 44(1):23–24 Szybalski W (1974) In vivo and in vitro initiation of transcription. Adv Exp Med Biol 44(1):23–24
8.
go back to reference Nose A (2010) The impact of patenting on synthetic biology inventions. Master thesis, Tilburg University Nose A (2010) The impact of patenting on synthetic biology inventions. Master thesis, Tilburg University
10.
go back to reference Bhutkar A (2005) Synthetic biology: navigating the challenges ahead. J Biolaw Bus 8(2):19–29 Bhutkar A (2005) Synthetic biology: navigating the challenges ahead. J Biolaw Bus 8(2):19–29
11.
go back to reference De Lorenzo V, Danchin A (2008) Synthetic biology: discovering new worlds and new words. EMBO Rep 9(9):822–827CrossRef De Lorenzo V, Danchin A (2008) Synthetic biology: discovering new worlds and new words. EMBO Rep 9(9):822–827CrossRef
12.
go back to reference Bentley L, Sherman B (2009) Intellectual property law, 3rd edn. Oxford University Press, New York Bentley L, Sherman B (2009) Intellectual property law, 3rd edn. Oxford University Press, New York
13.
go back to reference Rich GS (2004) Laying the ghost of the invention requirement. Fed Cir BJ 14(163) (reprint; orig. 1972) Rich GS (2004) Laying the ghost of the invention requirement. Fed Cir BJ 14(163) (reprint; orig. 1972)
14.
go back to reference Cornish W, Llewelyn D (2007) Intellectual property, 6th edn. Sweet & Maxwell, London Cornish W, Llewelyn D (2007) Intellectual property, 6th edn. Sweet & Maxwell, London
15.
go back to reference Madieha bt Abdul Ghani Azmi I (2003) Patent law in Malaysia: cases and commentary. Sweet & Maxwell Asia, Selangor Madieha bt Abdul Ghani Azmi I (2003) Patent law in Malaysia: cases and commentary. Sweet & Maxwell Asia, Selangor
16.
go back to reference Brune H, Ernst H, Grunwald A, Grünwald W, Hofmann H, Krug H et al (2006) Nanotechnology: assessment and perspectives, vol 27. Springer, Heidelberg Brune H, Ernst H, Grunwald A, Grünwald W, Hofmann H, Krug H et al (2006) Nanotechnology: assessment and perspectives, vol 27. Springer, Heidelberg
17.
go back to reference Halluin AP, Westin LP (2004) Nanotechnology: the importance of intellectual property rights in an emerging technology. J Pat & Trademark Off Soc'y 86(220):220–236 Halluin AP, Westin LP (2004) Nanotechnology: the importance of intellectual property rights in an emerging technology. J Pat & Trademark Off Soc'y 86(220):220–236
18.
go back to reference Schellekens M (2010) Patenting nanotechnology in Europe: making a good start? An analysis of issues in law and regulation. J World Intellect Prop 13(1):47–76 Schellekens M (2010) Patenting nanotechnology in Europe: making a good start? An analysis of issues in law and regulation. J World Intellect Prop 13(1):47–76
19.
go back to reference Bainbridge D (2002) Intellectual property, 5th edn. Pearson, England Bainbridge D (2002) Intellectual property, 5th edn. Pearson, England
20.
go back to reference Su Y-C (2009) What about know-how: heightened obviousness and lowered disclosure is not a panacea to the American patent system for biotechnology medication and pharmaceutical inventions in the post-KSR era. Marq Intell Prop L Rev 14(2): article 9 Su Y-C (2009) What about know-how: heightened obviousness and lowered disclosure is not a panacea to the American patent system for biotechnology medication and pharmaceutical inventions in the post-KSR era. Marq Intell Prop L Rev 14(2): article 9
21.
go back to reference Colston C (1999) Principles of intellectual property law. Cavendish, London Colston C (1999) Principles of intellectual property law. Cavendish, London
Metadata
Title
Person Skilled in the Art in Synthetic Biology from Iraqi and Malaysian Perspectives
Authors
Zinatul Ashiqin Zainol
Nabeel Mahdi Althabhawi
Publication date
03-03-2018
Publisher
Springer Netherlands
Published in
NanoEthics / Issue 1/2018
Print ISSN: 1871-4757
Electronic ISSN: 1871-4765
DOI
https://doi.org/10.1007/s11569-018-0311-3

Other articles of this Issue 1/2018

NanoEthics 1/2018 Go to the issue